1. High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPT 
Paolo Zocca, Marlies M. Kok, Liefke C. van der Heijden, K. Gert van Houwelingen, Marc Hartmann, Frits H.A.F. de Man, Martin G. Stoel, J.(Hans) W. Louwerenburg, Iris L. Knottnerus, Gerard C.M. Linssen, Carine J.M. Doggen, Clemens von Birgelen 
International Journal of Cardiology 
Volume 268, Pages (October 2018)
DOI: /j.ijcard
Copyright © 2018 The Authors Terms and Conditions

2. Fig. 1
One-year major bleeding and ischemic events for HBR and non-HBR patients.
Kaplan Meier curves for major bleeding and a composite ischemic endpoint consisting of cardiac death, any MI, or stroke in HBR (A, B) and non-HBR (C, D) patients treated during the clopidogrel period (orange) and the ticagrelor period (blue). Abbreviations: CP = clopidogrel period; HBR = high bleeding risk; MI = myocardial infarction; TP = ticagrelor period.
International Journal of Cardiology  , 11-17DOI: ( /j.ijcard )
Copyright © 2018 The Authors Terms and Conditions